Answers are grounded in this paper and cite their sources.
This open-label study provides evidence that crisaborole topical ointment, 2% was well tolerated, with limited systemic exposure under maximal-use conditions in patients ages 2 years and older.
No takes yet. Share an insight, caveat, or question.
Zane et al. (2016) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: